Last reviewed · How we verify

NCT05111782

Age Bias on Biopsychosocial Factors in Persons With Non-specific Low Back Pain.

Recruiting now NA Last updated 3 April 2024
What this trial tests

NA trial testing Symptom Modulation Approach, Movement Control Approach, Functional Optimization Approach in Low Back Pain in 280 participants. Currently enrolling.

Timeline
13 June 2022
Primary endpoint
1 March 2025
1 June 2025

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment280
Start date13 June 2022
Primary completion1 March 2025
Estimated completion1 June 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 20 to 60, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Low back pain is a debilitating condition experienced by people of all age groups. This study will be completed in two stages in which back pain assessment tools will be first translated to Urdu language and later on age-related bias on biopsychosocial factors will be assessed using various biopsychosocial tools over a period of six months.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Cross-Cultural Adaptation, Reliability, and Validity of Urdu Version of Örebro Musculoskeletal Pain Screening Questionnaire in Non-Specific Low Back Pain Patients.
    Naeem A, Glucina T, Umar M, Niazi IK, et al · · 2026 · PMID 41681064 · DOI 10.5535/arm.250155

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05111782.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing